NOVEL CRYSTAL FORMS OF 1-[5-METHANESULFONAMIDOINDOLYL-2-CARBONYL]-4-[3-(1-METHYLETHYLAMINO)-2-PYRIDINYL]PIPERAZINE

The present invention relates to two novel crystal forms of a known compound ,1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(11- methylethylamino)-2-pyridinyl]piperazine monomethanesulfonate salt, which ar e identified by a powder X-ray diffraction spectrum know n commonly as the "S" and...

Full description

Saved in:
Bibliographic Details
Main Authors SMITH, DONALD P, HAVENS, JEFFREY L, LYSTER, MARK A, BERGREN, MICHAEL S
Format Patent
LanguageEnglish
French
Published 03.05.2005
Edition6
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to two novel crystal forms of a known compound ,1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(11- methylethylamino)-2-pyridinyl]piperazine monomethanesulfonate salt, which ar e identified by a powder X-ray diffraction spectrum know n commonly as the "S" and "T" forms.
Bibliography:Application Number: CA19952184598